What does an elevated alpha-fetoprotein (AFP) level indicate?

Alpha-fetoprotein (AFP) is synthesized by fetal hepatocytes and the yolk sac. Its concentration in blood is high before birth but declines rapidly after delivery. Clinically, AFP serves as a serum biomarker for primary hepatocellular carcinoma (HCC), aiding in its diagnosis. Elevated AFP levels may result from various causes—including HCC, pregnancy, or viral hepatitis—and must be interpreted in conjunction with the patient’s individual clinical context. Prompt evaluation to rule out HCC is essential.

What does an elevated alpha-fetoprotein level indicate?

1. Hepatocellular carcinoma (HCC). HCC is one of the most common causes of elevated AFP. Notably, AFP levels often rise approximately eight months before clinical symptoms of HCC appear. Therefore, individuals with cirrhosis, chronic hepatitis, or a family history of HCC should undergo regular AFP screening based on their individual risk profile. Note: Relying solely on elevated AFP levels to diagnose or exclude a disease is unreliable.

2. Pregnancy. During gestation, maternal serum AFP levels increase significantly. AFP begins rising markedly around the third month of pregnancy, peaks between the seventh and eighth months, and remains relatively stable thereafter—though typically still below 400 μg/L. Levels usually return to normal within approximately three weeks postpartum.

3. Neonates. Transient elevation of AFP is normal in newborns, as AFP is a major plasma protein component during early embryonic development.

4. Neonatal hepatitis. Approximately 30% of infants with neonatal hepatitis test positive for AFP; detection rates and magnitude of elevation correlate with disease severity. This feature helps differentiate neonatal hepatitis from congenital biliary atresia, in which AFP levels are typically normal.

5. Non-malignant conditions. Mild-to-moderate AFP elevation may occur in various benign disorders—including acute or chronic hepatitis, recovery phase of severe hepatitis, cirrhosis, congenital biliary obstruction, and fetal structural anomalies. However, such elevations are generally modest and transient.

6. Germ cell tumors. According to available data, approximately 50% of patients with germ cell tumors exhibit elevated AFP. In male patients with AFP >25 μg/L, testicular cancer should be considered.

7. Viral hepatitis. During active phases of chronic viral hepatitis, AFP may rise mildly to moderately—typically ranging from 50 to 300 μg/L. Unlike in HCC, this elevation tends to be less pronounced, non-sustained, and resolves following effective treatment.

The above outlines key clinical implications of elevated alpha-fetoprotein. We hope this information is helpful to you.